Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB3 | P13945 | 1/20 | 0.37 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.37 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | PDE4B | Q07343 | 3/20 | 0.31 |
| ▸ | REN | P00797 | 1/20 | 0.31 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.30 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.30 |
| ▸ | NAMPT | P43490 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13711187 | 0.94 | ADRB3 (0.36) | ADRB3ADRA2BADRA2C | |
| SCHEMBL8277106 | 0.94 | ADRB3 (0.41) | ADRB3ADRA2BADRA2CCYP3A4PDE4B | |
| SCHEMBL13711266 | 0.93 | ADRB3 (0.36) | ADRB3ADRA2BADRA2CCYP3A4PDE4B | |
| SCHEMBL13711189 | 0.91 | ADRB3 (0.37) | ADRB3ADRA2BADRA2CCYP3A4PDE4B | |
| SCHEMBL13711267 | 0.89 | ADRB3 (0.40) | ADRB3ADRA2BADRA2CCYP3A4NAMPT | |
| SCHEMBL1655060 | 0.89 | ADRB3 (0.46) | ADRB3ADRA2BADRA2CCYP3A4PDE4B | |
| SCHEMBL1655063 | 0.89 | ADRB3 (0.46) | ADRB3ADRA2BADRA2CCYP3A4PDE4B | |
| SCHEMBL13818335 | 0.89 | ADRB3 (0.46) | ADRB3ADRA2BADRA2CCYP3A4PDE4B | |
| SCHEMBL3799240 | 0.89 | ADRB3 (0.46) | ADRB3ADRA2BADRA2CCYP3A4PDE4B | |
| SCHEMBL3799238 | 0.89 | ADRB3 (0.46) | ADRB3ADRA2BADRA2CCYP3A4PDE4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2103623-A2 | Novel macrocyclic inhibitors of Hepatitis C virus replication | Intermune, Inc. (US) | 2009-09-23 | — | — | EP | disclosed |